Two psychiatrists discuss the mechanisms of psychedelic compounds, including what sets them apart from standard approaches to psychiatric treatment and therapy, how to study them in a clinical research setting, and the potential risks and benefits of their emergence as a novel treatment for psychiatric disorders.